Killestein et al. found no significant differences in Th1 frequencies between MS phenotypes; however, this could be explained by their use of a short activation with PMA and ionomycin for 4 h, while we stimulated PBMC for 72 h in the presence of anti-CD3/CD28 (30). Here, CD28 is linked to myeloid sarcoma.